Triflusal: Difference between revisions
Content deleted Content added
No edit summary |
No edit summary |
||
| Line 25: | Line 25: | ||
}} |
}} |
||
'''Triflusal''' is a platelet aggregation inhibitor that was discovered and developed in the Uriach Laboratories, and commercialised in Spain since 1981. Currently, it is available in 25 countries in Europe, Asia, Africa and America. It is a drug of the salicylate family but it is not a derivative of [[acetylsalicylic acid]] (ASA). Trade name includes Disgren, Grendis, Aflen and Triflux<ref>Murdoch D, et al. Triflusal: a review of its use in cerebral infarction and myocardial infarction, and as thromboprophylaxis in atrial fibrillation. Drugs 2006; 66 (5):671-92 < |
'''Triflusal''' is a platelet aggregation inhibitor that was discovered and developed in the Uriach Laboratories, and commercialised in Spain since 1981. Currently, it is available in 25 countries in Europe, Asia, Africa and America. It is a drug of the salicylate family but it is not a derivative of [[acetylsalicylic acid]] (ASA). Trade name includes Disgren, Grendis, Aflen and Triflux<ref>Murdoch D, et al. Triflusal: a review of its use in cerebral infarction and myocardial infarction, and as thromboprophylaxis in atrial fibrillation. Drugs 2006; 66 (5):671-92 <ref/> |
||
==Mechanism of Action== |
==Mechanism of Action== |
||
* bl |
* bl |
||
Revision as of 07:00, 18 October 2009
 | |
| Clinical data | |
|---|---|
| ATC code | |
| Identifiers | |
| |
| PubChem CID | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.005.726 |
| Chemical and physical data | |
| Formula | C10H7F3O4 |
| Molar mass | 248.155 g/mol g·mol−1 |
Triflusal is a platelet aggregation inhibitor that was discovered and developed in the Uriach Laboratories, and commercialised in Spain since 1981. Currently, it is available in 25 countries in Europe, Asia, Africa and America. It is a drug of the salicylate family but it is not a derivative of acetylsalicylic acid (ASA). Trade name includes Disgren, Grendis, Aflen and Triflux<ref>Murdoch D, et al. Triflusal: a review of its use in cerebral infarction and myocardial infarction, and as thromboprophylaxis in atrial fibrillation. Drugs 2006; 66 (5):671-92 Cite error: The opening <ref> tag is malformed or has a bad name (see the help page).
Mechanism of Action
- bl
 | This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |